Search research articles
Contact Us
Filters
Showing results (1-10 of 126) with videos related to
Page
of 13
Sort By:
Plos Biology
|
June 5, 2015
Open access target validation is a more efficient way to accelerate drug discovery
Wen Hwa Lee
Molecular and Cellular Biology
|
October 1, 2003
Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage
Jeanho Yun, Wen-Hwa Lee
Advances in Cancer Research
|
October 11, 2002
Retinoblastoma tumor suppressor and genome stability
Lei Zheng, Wen-Hwa Lee
Cell Cycle (Georgetown, Tex.)
|
August 2, 2006
CtIP, a multivalent adaptor connecting transcriptional regulation, checkpoint control and tumor suppression
Guikai Wu, Wen-Hwa Lee
Molecular and Cellular Biology
|
April 4, 2006
CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression
Feng Liu, Wen-Hwa Lee
American Journal of Translational Research
|
February 26, 2010
From bench to bedside: the growing use of translational research in cancer medicine
Erin M Goldblatt, Wen-Hwa Lee
DNA Repair
|
July 29, 2004
The DNA double-strand break response pathway: becoming more BRCAish than ever
Nicholas S Y Ting, Wen-Hwa Lee
Ecancermedicalscience
|
September 6, 2016
Accelerating target discovery using pre-competitive open science-patients need faster innovation more than anyone else
Eric Low, Chas Bountra, Wen Hwa Lee
The Biochemical Journal
|
October 28, 2006
Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity
Petra Lukacik, Brigitte Keller, Gabor Bunkoczi, et al.
The Journal of Biological Chemistry
|
December 17, 2009
Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis
Kazi Mokim Ahmed, Connie Y Tsai, Wen-Hwa Lee
Page
of 13
Search research articles
Search
Showing results (1-10 of 126) with videos related to
Sort By:
Page
of 13
Plos Biology
|
June 5, 2015
Open access target validation is a more efficient way to accelerate drug discovery
Wen Hwa Lee
Molecular and Cellular Biology
|
October 1, 2003
Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage
Jeanho Yun, Wen-Hwa Lee
Advances in Cancer Research
|
October 11, 2002
Retinoblastoma tumor suppressor and genome stability
Lei Zheng, Wen-Hwa Lee
Cell Cycle (Georgetown, Tex.)
|
August 2, 2006
CtIP, a multivalent adaptor connecting transcriptional regulation, checkpoint control and tumor suppression
Guikai Wu, Wen-Hwa Lee
Molecular and Cellular Biology
|
April 4, 2006
CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression
Feng Liu, Wen-Hwa Lee
American Journal of Translational Research
|
February 26, 2010
From bench to bedside: the growing use of translational research in cancer medicine
Erin M Goldblatt, Wen-Hwa Lee
DNA Repair
|
July 29, 2004
The DNA double-strand break response pathway: becoming more BRCAish than ever
Nicholas S Y Ting, Wen-Hwa Lee
Ecancermedicalscience
|
September 6, 2016
Accelerating target discovery using pre-competitive open science-patients need faster innovation more than anyone else
Eric Low, Chas Bountra, Wen Hwa Lee
The Biochemical Journal
|
October 28, 2006
Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity
Petra Lukacik, Brigitte Keller, Gabor Bunkoczi, et al.
The Journal of Biological Chemistry
|
December 17, 2009
Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis
Kazi Mokim Ahmed, Connie Y Tsai, Wen-Hwa Lee
Page
of 13